Publications by authors named "Luis Mas"

Claim this Profile
M
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations.
John P McElderry, Tongwu Zhang, Wei Zhao, Phuc H Hoang, Samuel Anyaso-Samuel, Luis Mas

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer' [Journal of Thoracic Oncology, Volume 19 Issue 1 (2024) 119-129].
Luis Lara-Mejía, Andres F Cardona, Luis Mas, Claudio Martin, Suraj Samtani

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic signature for lung adenocarcinoma in patients who have never smoked.
Wei Zhao, Tongwu Zhang, Xing Hua, Phuc H Hoang, Mona Miraftab, Luis Mas

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic signature for lung adenocarcinoma in people who have never smoked.
Wei Zhao, Tongwu Zhang, Xing Hua, Phuc H Hoang, Mona Miraftab, Luis Mas

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Erlotinib vs. Osimertinib for Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Without Prior Treatment: A Network Meta-Analysis.
Fernando M Runzer-Colmenares, Rossana Ruiz, Lorenzo Maco, Mike Maldonado, Luis Puma-Villanueva, Luis Mas

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical practice and outcomes in Peruvian patients with advanced EGFR T790M mutation positive NSCLC: A multicenter analysis.
Marco Galvez-Nino, Katia Roque, Rossana Ruiz, Fernando Namuche, Victor Paitan, Luis Mas

Cancer Treat Res Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM).
Diego Enrico, Juan Elias Gomez, Danilo Aguirre, Natalia Soledad Tissera, Florencia Tsou, Luis Mas

Clin Lung Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC.
Luis Lara-Mejía, Andres F Cardona, Luis Mas, Claudio Martin, Suraj Samtani

J Thorac Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices.
Katia Roque, Rossana Ruiz, Luis Mas, Daniel Humberto Pozza, Marina Vancini

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer subtype and clinical characteristics in women from Peru.
Valentina A Zavala, Sandro Casavilca-Zambrano, Jeannie Navarro-Vásquez, Lizeth I Tamayo, Carlos A Castañeda, Luis Mas

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru.
Marco Galvez-Nino, Rossana Ruiz, Katia Roque, Ofelia Coanqui, Natalia Valdivieso, Luis Mas

Thorac Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
David Heredia, Luis Mas, Andres F Cardona, Víctor Oyervides, Rodrigo Motta Guerrero

Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic.
Katia Roque, Rossana Ruiz, Iris Otoya-Fernandez, José Galarreta, Tatiana Vidaurre, Luis Mas

Future Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Andrés F Cardona, Alejandro Ruiz-Patiño, Gonzalo Recondo, Claudio Martín, Luis Raez

Clin Lung Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of lung cancer in the young.
Rossana Ruiz, Marco Galvez-Nino, Katia Roque, Jaime Montes, Maria Nuñez, Luis Mas

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Vladmir C Cordeiro de Lima, Marcelo Corassa, Erick Saldanha, Helano Freitas, Oscar Arrieta

Lung Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).
Luis E Raez, Oscar Arrieta, Diego F Chamorro, Pamela Denisse Soberanis-Piña, Luis Corrales, Luis Mas

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics.
Alejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, Jenny Ávila, Pilar Archila, Luis Mas

Transl Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA.
Alfredo Aguilar, Luis Mas, Daniel Enríquez, Carlos Vallejos, Rosa Gutarra

Cancer Control· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).
Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, Juan Esteban Garcia-Robledo, Lucia Zatarain Barron, Luis Mas

JCO Precis Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP-LATimus).
Claudio Martín, Diego Enrico, Luis Mas, Ana Karina Patane, Oscar Arrieta

Thorac Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution.
Patricia Rioja, Rossana Ruiz, Marco Galvez-Nino, Sophia Lozano, Natalia Valdiviezo, Luis Mas

Thorac Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study).
Alejandro Ruiz-Patiño, Andrés Felipe Cardona, Oscar Arrieta, Christian Rolfo, Henry L Gómez, Luis Mas

J Clin Epidemiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.
Oscar Arrieta, Andrés F Cardona, Luis Lara-Mejía, David Heredia, Feliciano Barrón, Luis Mas

Crit Rev Oncol Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP).
Alejandro Ruiz-Patiño, Feliciano Barrón, Andrés F Cardona, Luis Corrales, Luis Mas

Thorac Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis